Rezultati
eNauka >
Rezultati >
CYP2C19*2 variant is a predictor of poor clopidigrel response and can be base for the economically rationalized antiagregation therapy protocol in Serbian population
![](https://cdn3.iconfinder.com/data/icons/flat-actions-icons-9/512/Tick_Mark-256.png)
Naziv: | CYP2C19*2 variant is a predictor of poor clopidigrel response and can be base for the economically rationalized antiagregation therapy protocol in Serbian population | Autori: | Rakicević, Ljiljana ![]() ![]() ![]() ![]() ![]() ![]() |
Godina: | 2019 | Publikacija: | 6thMeeting of European Section and 7th Meeting of North American Section of the International Academy of Cardiovascular Sciences (IACS) | Tip rezultata: | Konferencijski rad | URI: | https://enauka.gov.rs/handle/123456789/773558 | URL: | http://www.physiology.org.rs/eng/htm/konf2019/6th%20Meeting%20of%20the%20IACS%202019%20( Final%20Program).pdf | Izvor metapodataka: | (Preuzeto iz ORCID-a) Novkovic, Mirjana | M-kategorija: | Mp kategorija će biti prikazana naknadno. |
Rezultati na eNauka su zaštićeni autorskim pravima i sva prava su zadržana, osim ako nije drugačije naznačeno.